These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35108311)

  • 21. Influence of heterogeneous age-group contact patterns on critical vaccination rates for herd immunity to SARS-CoV-2.
    Saldaña J; Scoglio C
    Sci Rep; 2022 Feb; 12(1):2640. PubMed ID: 35173229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Core Concept: Herd immunity is an important-and often misunderstood-public health phenomenon.
    McDermott A
    Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34011611
    [No Abstract]   [Full Text] [Related]  

  • 23. Can COVID-19 herd immunity be achieved at a city level?
    Arbel Y; Arbel Y; Kerner A; Kerner M
    PLoS One; 2024; 19(5):e0299574. PubMed ID: 38809902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Will SARS-CoV-2 Become Just Another Seasonal Coronavirus?
    Beams AB; Bateman R; Adler FR
    Viruses; 2021 May; 13(5):. PubMed ID: 34067128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenges of vaccination and herd immunity in COVID-19 and management strategies.
    She J; Hou D; Chen C; Bi J; Song Y
    Clin Respir J; 2022 Nov; 16(11):708-716. PubMed ID: 36172975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Will achieving herd immunity be a road to success to end the COVID-19 pandemic?
    Kwok KO; McNeil EB; Tsoi MTF; Wei VWI; Wong SYS; Tang JWT
    J Infect; 2021 Sep; 83(3):381-412. PubMed ID: 34118274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Individual preferences for COVID-19 vaccination in China.
    Leng A; Maitland E; Wang S; Nicholas S; Liu R; Wang J
    Vaccine; 2021 Jan; 39(2):247-254. PubMed ID: 33328140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Could COVID-19 be contained in poor populations by herd immunity rather than by strategies designed for affluent societies or potential vaccine(s)?
    Ruppel A; Halim MI; Kikon R; Mohamed NS; Saebipour MR
    Glob Health Action; 2021 Jan; 14(1):1863129. PubMed ID: 33397199
    [No Abstract]   [Full Text] [Related]  

  • 29. COVID-19 pandemic and vaccination build herd immunity.
    Redwan EM
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):577-579. PubMed ID: 33577008
    [No Abstract]   [Full Text] [Related]  

  • 30. Can Africa achieve herd immunity?
    Lucero-Prisno DE; Ogunkola IO; Esu EB; Adebisi YA; Lin X; Li H
    Glob Health Res Policy; 2021 Dec; 6(1):46. PubMed ID: 34852844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On reaching herd immunity during the COVID-19 pandemic and further issues.
    Pandolfi S; Chirumbolo S
    J Med Virol; 2022 Jan; 94(1):24-25. PubMed ID: 34491592
    [No Abstract]   [Full Text] [Related]  

  • 32. COVID-19 vaccination for children: may be necessary for the full eradication of the disease.
    Praticò AD; Ruggieri M
    Pediatr Res; 2021 Dec; 90(6):1102-1103. PubMed ID: 34253861
    [No Abstract]   [Full Text] [Related]  

  • 33. A flexible age-dependent, spatially-stratified predictive model for the spread of COVID-19, accounting for multiple viral variants and vaccines.
    Schneider KA; Tsoungui Obama HCJ; Adil Mahmoud Yousif N
    PLoS One; 2023; 18(1):e0277505. PubMed ID: 36662784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing vaccination priorities for different ages and age-specific vaccination strategies of COVID-19 using an SEIR modelling approach.
    Yang C; Yang Y; Li Y
    PLoS One; 2021; 16(12):e0261236. PubMed ID: 34936650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparing for the Coronavirus Disease (COVID-19) Vaccination: Evidence, Plans, and Implications.
    Jung J
    J Korean Med Sci; 2021 Feb; 36(7):e59. PubMed ID: 33619920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Individuals cannot rely on COVID-19 herd immunity: Durable immunity to viral disease is limited to viruses with obligate viremic spread.
    Yewdell JW
    PLoS Pathog; 2021 Apr; 17(4):e1009509. PubMed ID: 33901246
    [No Abstract]   [Full Text] [Related]  

  • 37. [Review of the concept of herd immunity, in the context of COVID-19 epidemic and the development of vaccines].
    Canals L M
    Rev Chilena Infectol; 2021 Aug; 38(4):495-499. PubMed ID: 34652394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 exit strategy during vaccine implementation: a balance between social distancing and herd immunity.
    Daher-Nashif S; Al-Anany R; Ali M; Erradi K; Farag E; Abdallah AM; Emara MM
    Arch Virol; 2022 Sep; 167(9):1773-1783. PubMed ID: 35723757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimal vaccine allocation for COVID-19 in the Netherlands: A data-driven prioritization.
    Miura F; Leung KY; Klinkenberg D; Ainslie KEC; Wallinga J
    PLoS Comput Biol; 2021 Dec; 17(12):e1009697. PubMed ID: 34898617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endemic SARS-CoV-2 will maintain post-pandemic immunity.
    Veldhoen M; Simas JP
    Nat Rev Immunol; 2021 Mar; 21(3):131-132. PubMed ID: 33402727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.